Hepatocarcinoma fibrolamelar un tumor de adultos jóvenes poco frecuente. . Dentro de los diagnósticos diferenciales se debe considerar la HNF, CHC. Protocolo de diagnóstico diferencial de las lesiones ocupantes de espacio en el hígado cirrótico Clinical management of hepatocellular carcinoma. Su diagnóstico suele ser tardío, ya que se presenta en pacientes jóvenes, sin . a las del hepatocarcinoma en la que es necesario un diagnóstico diferencial.

Author: Neshakar Arashijin
Country: Barbados
Language: English (Spanish)
Genre: Automotive
Published (Last): 20 June 2016
Pages: 176
PDF File Size: 18.5 Mb
ePub File Size: 13.61 Mb
ISBN: 575-3-13651-175-6
Downloads: 27427
Price: Free* [*Free Regsitration Required]
Uploader: Kazirn

Thus, high-grade dysplastic nodules tend to be hypovascular in the arterial and portal phases, but may also become hypervascular in the arterial phase in cases where the abnormal arterial vascularization is more developed. Computed body tomography with MRI correlation. Well-differentiated HCCs contain functioning hepatocytes and might show hepatobiliary contrast uptake. Although containing functioning hepatocytes, there is a lack of biliary ducts resulting in deficiency in bilirubin and hepatobiliary contrast excretion.

HEPATOCARCINOMA DE CÈLULAS CLARAS by marta garnica ureña on Prezi

The metastatic implants that do not contain hepatocytes become hypointense. Male, year-old dierencial presenting with chronic hepatopathy and liver nodule to be clarified, adjacent to the gallbladder, as seen at ultrasonography.

Homogeneous hepatobiliary contrast uptake indicates the diagnosis of FNH. Other applications of hepatobiliary contrast agents include the evaluation of the biliary flow dynamics, the study of partial or complete biliary duct obstructions, and the localization of the stenosis site. Case reports in oncology ; 5 1: Clinicopathologic features and survival in fibrolamellar carcinoma: Contrast enhancement of liver lesions in cirrhotic patients: Vilgrain V, Vullierme MP. The use of hepatobiliary contrast agents requires some care.


Hepatobiliary contrast allow for the differentiation between FNH and adenoma in most cases, even in those of small lesions. All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License.

Fibrolamellar hepatocellular carcinoma: a case report

Further potential hepatobiliary contrast applications include evaluation of the functional hepatic reserve before partial hepatectomy; evaluation of live donor’s hepatic function as well as evaluation of early liver failure after transplant. Imaging evaluation of congenital cystic lesions of the biliary tract. As the gadoxetic acid dose corresponds to one quarter of the habitual extracellular gadolinium dose, the arterial phase acquisition time is critical, requiring temporal precision methods, such as real time visualization of the contrast progression through the arterial system, for the hepatocarcinima in this phase acquisition.

Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid Gd-EOB-DTPA for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging. Focal liver lesions enhancement may be less intense during the dynamic study, particularly diagnoostico the arterial phase, because the recommended dose of hepatocarcionma acid is lower than the habitual extracellular gadolinium dose 5.

Advances in anatomic pathology ; 14 3: On the other hand, the lesions showed homogeneous hepatobiliary contrast uptake, hence the highest likelihood of the diagnosis of hwpatocarcinoma FNHs. The imaging characterization of benign and malignant liver lesions is very important. AMA journal of diseases of children ; 91 2: Considering that the presence of intralesional fat in NFH is rare, the patient will be maintained under imaging follow-up.

Adverse effects of hepatobiliary contrast hepatocagcinoma rarely occur and, if present, are similar to the ones reported in the use of extra-cellular gadolinium. Primary and secondary hepatic neoplasms.

Services on Demand Article.


There was a problem providing the content you requested

Main indications for hepatobiliary contrast include differentiation between focal nodular hyperplasia FNH and adenoma, characterization of hepatocelular carcinomas HCCsdetection of small liver metastasis, assessment of biliary anatomy, and characterization of postoperative biliary fistulas.

Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: Cecil Tratado de medicina interna. Also, in the delayed-phase, the fill-in pattern is not diaynostico, which might occur with the utilization of hepatobiliary contrast agent.

The utilization of hepatobiliary contrast agents increases the MRI accuracy, reducing the necessity of invasive diagnostic procedures intended to clarify the diagnosis of nonspecific lesions 12.

The utilization of such contrast agents increases the index of detection of hypo- and hypervascular metastases Figure 7. Cancer ; Male, year-old patient presenting with chronic C virus hepatopathy.

Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma–results and treatment recommendations from the Childhood Liver Tumour Strategy Group SIOPEL experience. A diferehcial confusion factor is the fact that some hemangiomas may present subtle central contrast uptake during the early hepatobiliary phase because of the tendency to persistent centripetal enhancement at dynamic study, like in those with extracellular gadolinium 1.

Such contrast agents shortens the T1 relaxation time of the bile and allows for the performance of a high-resolution T1-weighted cholangiography 4. Cancer ; 46 2: A US population-based study.

Fibrolamellar variant of hepatocellular carcinoma.